IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Kinnevik AB (publ)

Q4 2023 Holdings

Filed 2024-02-02 | 1 holdings | $102.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Recursion Pharmaceuticals, Inc.(RXRX)CL A75629V104$102.6M10,405,668100.0%